Abstract: The invention relates to a composite multilayer carbon dioxide (CO2) reduction catalyst, comprising a catalyst layer comprising at least one metal compound, the catalyst layer having opposed first and second sides; a hydrophobic gas-diffusion layer provided on the first side of the catalyst layer; a current collection structure provided on the second side of the catalyst layer. The metal is preferably copper. The invention also relates to a method for electrochemical production of a hydrocarbon product, such as ethylene, using said catalyst.

Abstract: An abrupt interface electroreduction catalyst includes a porous gas diffusion layer and a catalyst layer providing a sharp reaction interface. The electroreduction catalyst can be used for converting CO2 into a target product such as ethylene. The porous gas diffusion layer can be hydrophobic and configured for contacting gas-phase CO2 while the catalyst layer is disposed on and covers a reaction interface side of the porous gas diffusion layer. The catalyst layer has another side contacting an electrolyte and can be hydrophilic, composed a metal such as Cu and is sufficiently thin to prevent diffusion limitations of the reactant in the electrolyte and enhance selectivity for the target product. The electroreduction catalyst can be made by vapor deposition methods and can be used for electrochemical production of ethylene in reaction system.

Abstract: The disclosure provides in its first aspect a catalyst system for gas-phase electrolysis of a reactant gas to form a product in an aqueous medium, the catalyst system comprising a catalytic material; an ion-conducting polymer layer provided on the catalytic material and comprising an ion-conducting polymer that includes hydrophilic and hydrophobic groups. Said catalyst system is remarkable in that the ion-conducting polymer layer has a thickness of 2 nm to 50 nm measured by transmission-electron microscopy. In its second aspect, the disclosure provides a method of manufacturing a catalyst system for gas-phase electrolysis of reactant gas to produce a product in an aqueous medium preferably according to the first aspect. The use of the catalyst system in accordance with the first aspect in the electrochemical production of at least one multi-carbon compound from a carbon-containing gas or of at least one product from a reactant gas is also disclosed.

Abstract: The present disclosure provides substantially homogeneously dispersed multimetal oxy-hydroxide catalyst comprising at least two metals, at least one metal being a transition metal, and at least a second metal which is structurally dissimilar to at least one metal, such that the multimetal oxy-hydroxide is characterized by being substantially homogeneously dispersed and generally not crystalline. A key feature of the present materials is that the presence of the structurally dissimilar metal results in sufficient strain produced in the final multimetal oxy-hydroxide material to prevent crystallization from occurring. The resulting materials are specifically not annealed at temperatures that would induce crystallization in order to avoid the expected phase segregation that would occur during crystallization.

Abstract: The invention relates to a composite multilayer carbon dioxide (CO2) reduction catalyst, comprising a catalyst layer comprising at least one metal compound, the catalyst layer having opposed first and second sides; a hydrophobic gas-diffusion layer provided on the first side of the catalyst layer; a current collection structure provided on the second side of the catalyst layer. The metal is preferably copper. The invention also relates to a method for electrochemical production of a hydrocarbon product, such as ethylene, using said catalyst.

Abstract: An abrupt interface electroreduction catalyst includes a porous gas diffusion layer and a catalyst layer providing a sharp reaction interface. The electroreduction catalyst can be used for converting CO2 into a target product such as ethylene. The porous gas diffusion layer can be hydrophobic and configured for contacting gas-phase CO2 while the catalyst layer is disposed on and covers a reaction interface side of the porous gas diffusion layer. The catalyst layer has another side contacting an electrolyte and can be hydrophilic, composed a metal such as Cu and is sufficiently thin to prevent diffusion limitations of the reactant in the electrolyte and enhance selectivity for the target product. The electroreduction catalyst can be made by vapor deposition methods and can be used for electrochemical production of ethylene in reaction system.

Abstract: The present disclosure provides substantially homogeneously dispersed multimetal oxy-hydroxide catalyst comprising at least two metals, at least one metal being a transition metal, and at least a second metal which is structurally dissimilar to at least one metal, such that the multimetal oxy-hydroxide is characterized by being substantially homogeneously dispersed and generally not crystalline. A key feature of the present materials is that the presence of the structurally dissimilar metal results in sufficient strain produced in the final multimetal oxy-hydroxide material to prevent crystallization from occurring. The resulting materials are specifically not annealed at temperatures that would induce crystallization in order to avoid the expected phase segregation that would occur during crystallization.

Abstract: A heat transfer system is adapted for transferring heat between two different ducts in a ventilation system. The system has a heat pipe having a plurality of conduits. Each conduit including an evaporator section extending laterally from a first open end of the respective conduit, a condenser section extending laterally from a second open end of the respective conduit, and a liquid return section. The liquid return section of at least one conduit being distinct from the liquid return section of another of the conduits. A common vapor manifold is in fluid communication with and extends between the first and second open ends of each of said plurality of conduits so vapors produced in the evaporator sections can flow from the first open ends through the common vapor manifold to the second open ends without flowing through the conduits.

Abstract: A system and method is provided for determining flow profiles in a deviated well. The system and method utilize temperature measurements and a modeling technique that enable the use of temperature profiles in deriving flow profiles for fluid injected into deviated wells.

Abstract: This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

Abstract: The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I: wherein the wavy segments represent ? or ? bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2 and R3 are as defined in the specification.

Abstract: This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

Abstract: The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I: wherein the wavy segments represent ? or ? bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2 and R3 are as defined in the specification.

Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; wherein X, Y, Z, D and R3 are as defined in the specification.

Abstract: The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I: wherein the wavy segments represent ? or ? bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2 and R3 are as defined in the specification.

Abstract: The present invention provides a compound represented by the general formula I; wherein A, Ar, X, Z, n, x, y, R and R3 are as defined in the specification.

Abstract: This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; 1

Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; 1

Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; wherein X, Y, Z, D and R3 are as defined in the specification.